Jyothy Labs Ltd
Jyothy Labs Ltd (JYOTHYLAB) last reported results for the quarter ended Mar 2025, with sales of ₹667 crore and net profit of ₹76 crore. The stock last traded at ₹182, a market capitalisation of ₹6,683 crore, on a P/E of 18.2. Over the past 52 weeks the stock has ranged between ₹180 and ₹325. Figures are as of 6 Oct 2026 and are not real time.
Jyothy Labs Ltd share price and key metrics
- Current price
- ₹182
- Market cap
- ₹6,683 cr
- Stock P/E
- 18.2
- Book value
- ₹55.8
- ROE
- 19.0%
- ROCE
- 24.6%
- Dividend yield
- 1.91%
- 52w high / low
- 325/180
Metrics as of 6 Oct 2026. Not real time.
Track Jyothy Labs Ltd
Cruxal reads every Jyothy Labs Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Jyothy Labs Ltd growth and returns
- 10 Years
- 7%
- 5 Years
- 11%
- 3 Years
- 9%
- TTM
- 3%
- 10 Years
- 12%
- 5 Years
- 16%
- 3 Years
- 32%
- TTM
- 3%
- 10 Years
- 0%
- 5 Years
- 2%
- 3 Years
- -21%
- 1 Year
- -42%
- 10 Years
- 16%
- 5 Years
- 17%
- 3 Years
- 18%
- Last Year
- 19%
Jyothy Labs Ltd quarterly results
In the quarter ended Mar 2025, sales were ₹667 cr, up 1.1% from ₹660 cr a year earlier. Net profit was ₹76 cr, down 2.6% year on year.
| ₹ crore | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 687 | 732 | 678 | 660 | 742 | 734 | 704 | 667 |
| Expenses | 570 | 597 | 559 | 552 | 608 | 595 | 589 | 555 |
| Operating profit | 117 | 135 | 119 | 108 | 133 | 138 | 116 | 112 |
| OPM % | 17% | 18% | 18% | 16% | 18% | 19% | 16% | 17% |
| Other income | 17 | 13 | 11 | 13 | 14 | 13 | 14 | 11 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| Depreciation | 12 | 12 | 13 | 13 | 13 | 14 | 14 | 15 |
| Profit before tax | 121 | 135 | 115 | 107 | 132 | 136 | 114 | 107 |
| Tax % | 21% | 23% | 21% | 27% | 23% | 23% | 23% | 29% |
| Net profit | 96 | 104 | 91 | 78 | 102 | 105 | 87 | 76 |
| EPS (₹) | 2.62 | 2.84 | 2.48 | 2.13 | 2.77 | 2.86 | 2.38 | 2.08 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Jyothy Labs Ltd annual results
| ₹ crore | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,593 | 1,683 | 1,672 | 1,814 | 1,711 | 1,909 | 2,196 | 2,486 | 2,757 | 2,847 |
| Operating profit | 223 | 255 | 257 | 282 | 251 | 315 | 248 | 316 | 480 | 500 |
| OPM % | 14% | 15% | 15% | 16% | 15% | 16% | 11% | 13% | 17% | 18% |
| Net profit | 74 | 204 | 179 | 198 | 163 | 191 | 159 | 240 | 369 | 370 |
| EPS (₹) | 2.16 | 5.73 | 5.12 | 5.59 | 4.64 | 5.43 | 4.41 | 6.53 | 10.06 | 10.09 |
TTM is the trailing twelve months to the most recent quarter.
Jyothy Labs Ltd balance sheet
| ₹ crore | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 18 | 18 | 18 | 37 | 37 | 37 | 37 | 37 | 37 | 37 |
| Reserves | 883 | 1,071 | 1,126 | 1,290 | 1,192 | 1,392 | 1,407 | 1,512 | 1,772 | 2,013 |
| Borrowings | 451 | 498 | 544 | 281 | 285 | 117 | 171 | 47 | 51 | 61 |
| Other liabilities | 417 | 266 | 291 | 335 | 323 | 410 | 408 | 466 | 542 | 580 |
| Total liabilities | 1,770 | 1,853 | 1,979 | 1,942 | 1,836 | 1,956 | 2,023 | 2,062 | 2,401 | 2,691 |
| Fixed assets | 1,068 | 1,097 | 1,091 | 1,101 | 1,149 | 1,147 | 1,122 | 1,116 | 1,125 | 1,141 |
| CWIP | 8 | 9 | 15 | 14 | 24 | 10 | 8 | 15 | 13 | 22 |
| Investments | 86 | 28 | 113 | 104 | 0 | 0 | 0 | 0 | 192 | 456 |
| Other assets | 608 | 719 | 760 | 723 | 662 | 799 | 893 | 930 | 1,071 | 1,071 |
| Total assets | 1,770 | 1,853 | 1,979 | 1,942 | 1,836 | 1,956 | 2,023 | 2,062 | 2,401 | 2,691 |
As reported by the company. Total assets equal total liabilities by construction.
Jyothy Labs Ltd cash flow
| ₹ crore | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 192 | 163 | 242 | 302 | 171 | 402 | 203 | 329 | 458 | 311 |
| Cash from investing | 108 | -17 | -74 | 30 | 72 | -129 | -32 | -48 | -344 | -161 |
| Cash from financing | -302 | -130 | -145 | -318 | -304 | -216 | -167 | -251 | -135 | -157 |
| Net cash flow | -2 | 16 | 23 | 13 | -60 | 57 | 4 | 30 | -21 | -7 |
| Free cash flow | 166 | 107 | 247 | 263 | 130 | 377 | 181 | 316 | 443 | 254 |
| CFO / operating profit | 109% | 76% | 104% | 122% | 84% | 138% | 94% | 122% | 112% | 82% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Jyothy Labs Ltd operating ratios
| Per year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 15% | 16% | 15% | 17% | 14% | 19% | 13% | 18% | 27% | 25% |
| Debtor days | 22 | 25 | 35 | 31 | 26 | 18 | 24 | 20 | 27 | 35 |
| Inventory days | 81 | 80 | 79 | 76 | 91 | 101 | 85 | 77 | 74 | 84 |
| Days payable | 70 | 61 | 63 | 67 | 53 | 69 | 67 | 55 | 72 | 75 |
| Cash conversion cycle | 32 | 45 | 51 | 40 | 65 | 49 | 41 | 42 | 29 | 45 |
| Working capital days | -114 | -85 | -87 | -33 | -27 | -8 | -1 | 13 | 40 | 39 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Jyothy Labs Ltd shareholding pattern
Promoters held 62.89% at Jun 2026, broadly unchanged since Jun 2025. FIIs 12.13% and DIIs 13.36%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 62.89% | 62.89% | 62.88% | 62.88% | 62.88% | 62.89% | 62.89% | 62.89% |
| FIIs | 15.10% | 14.35% | 13.13% | 12.66% | 12.11% | 12.77% | 12.35% | 12.13% |
| DIIs | 15.26% | 15.25% | 16.25% | 15.98% | 16.08% | 15.14% | 14.62% | 13.36% |
| Government | 0.00% | 0.00% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public | 6.75% | 7.50% | 7.72% | 8.48% | 8.91% | 9.19% | 10.13% | 11.61% |
| No. of shareholders | 1,63,046 | 1,94,753 | 2,09,200 | 2,20,538 | 2,17,305 | 2,23,801 | 2,33,314 | 2,47,104 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Jyothy Labs Ltd corporate filings
- Compliance certificate under Regulation 74(5) od SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026Company Updatelow impact
- Allotment of Equity Shares under ESOP for Jyothy Labs Ltd on 2026-10-05Company Updatelow impact
Cruxal's analysis: Jyothy Labs announced the allotment of equity shares pursuant to the exercise of…
Read the full analysis - Intimation under regulation 30 of SEBI LODR Regulations, 2015Company Updatelow impact
- Intimation of Closure of Trading Window for the quarter and half year ended September 30, 2026.Insider Trading / SASTlow impact
- Jyothy Labs Ltd discloses credit rating update under SEBI Regulation 30Company Updatelow impact
Cruxal's analysis: Jyothy Labs Ltd has filed a disclosure regarding its credit rating under Regulation 30 of…
Read the full analysis - Jyothy Labs Ltd schedules analyst/investor meetingCompany Updatelow impact
Cruxal's analysis: Jyothy Labs has issued an intimation regarding an upcoming analyst/investor meeting in…
Read the full analysis - Jyothy Labs Ltd schedules analyst/investor meetingCompany Updatelow impact
Cruxal's analysis: Jyothy Labs has issued an intimation regarding an upcoming analyst/investor meeting. The…
Read the full analysis - Jyothy Labs Ltd schedules analyst/investor meeting for September 15, 2026Company Updatelow impact
Cruxal's analysis: Jyothy Labs has issued a formal intimation under Regulation 30 of the SEBI (LODR)…
Read the full analysis - Nalanda India Equity Fund Increases Stake in Jyothy Labs Limited to 7.60%Insider Trading / SASTmedium impact
Cruxal's analysis: Nalanda India Equity Fund Limited has increased its shareholding in Jyothy Labs Limited…
Read the full analysis - Jyothy Labs Ltd schedules analyst/investor meetingCompany Updatelow impact
Cruxal's analysis: Jyothy Labs Ltd has issued an intimation regarding an upcoming analyst/investor meet. The…
Read the full analysis - Jyothy Labs Ltd schedules analyst/investor meetingCompany Updatelow impact
Cruxal's analysis: Jyothy Labs has issued an intimation regarding an upcoming analyst/investor meeting in…
Read the full analysis - Jyothy Labs Ltd announces upcoming analyst/investor meetingCompany Updatelow impact
Cruxal's analysis: Jyothy Labs Ltd has filed an intimation regarding an upcoming analyst/investor meeting in…
Read the full analysis - Jyothy Labs Ltd schedules analyst/investor meetingCompany Updatelow impact
Cruxal's analysis: Jyothy Labs Ltd has issued an intimation regarding an upcoming analyst/investor meeting…
Read the full analysis - Jyothy Labs Ltd announces upcoming analyst/investor meetingCompany Updatelow impact
Cruxal's analysis: Jyothy Labs has issued an intimation regarding a scheduled analyst/investor meeting. The…
Read the full analysis - Nalanda India Equity Fund Increases Stake in Jyothy Laboratories Limited to 7.61%Insider Trading / SASTmedium impact
Cruxal's analysis: Nalanda India Equity Fund Limited has increased its shareholding in Jyothy Laboratories…
Read the full analysis - Jyothy Labs Ltd discloses NSE ESG rating under Regulation 30Company Updatelow impact
Cruxal's analysis: Jyothy Labs has submitted a disclosure regarding its NSE ESG rating in compliance with…
Read the full analysis - Jyothy Labs Ltd schedules analyst/investor meetingCompany Updatelow impact
Cruxal's analysis: Jyothy Labs has issued an intimation regarding an upcoming analyst/investor meeting in…
Read the full analysis - Jyothy Labs Ltd: Routine Regulatory Disclosure under SEBI LODRCompany Updatelow impact
Cruxal's analysis: Jyothy Labs Ltd has filed a routine announcement under Regulation 30 of the SEBI (LODR)…
Read the full analysis - Jyothy Labs Q1 FY27 Earnings Call: Margin Compression Due to Crude-Linked Input Inflation; Strategic Focus on Portfolio DiversificationCompany Updatehigh impact
Cruxal's analysis: Jyothy Labs reported significant margin pressure in Q1 FY27, with gross margins…
Read the full analysis - Jyothy Labs Ltd publishes mandatory newspaper notice regarding Regulation 30Company Updatelow impact
Cruxal's analysis: Jyothy Labs Ltd has fulfilled its statutory obligation under SEBI (LODR) Regulations by…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.